Upadacitinib is effective in inducing clinical response and remission and is generally well tolerated in patients with ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

For too long you have suffered from inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Crohn’s disease.

For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy ...

Guselkumab (Tremfya) showed higher 24-week fistula remission than placebo in adults with perianal fistulizing Crohn disease.

Abdominal surgeries, disease progression, and hospitalizations all reduced vs step-up appr ...

For patients with Crohn disease and ulcerative colitis (UC), a fixed-dose co-antibody therapy JNJ-4804 is efficacious.

As in symptomatic Crohn’s disease, inflammation is occurring in the digestive tract, but symptoms may be subtle or even absent, leaving people with the condition unaware that anything is wrong. It can ...

Finding out you have a long-term condition like Crohn's disease can cause a mix of emotions. You might be worried or sad. You could be in denial. Or you may feel like it’s your fault that you have ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Crohn’s disease is an inflammatory bowel disease (IBD) that causes chronic inflammation of your gastrointestinal (GI) tract. This disease can affect any of the organs making up your GI tract: mouth, ...

Scientists haven’t identified all the many causes of Crohn’s disease, but they’ve found certain groups of people who seem to be at higher risk. Over 3 million people in the U.S. have Crohn’s disease.